Lineage Cell Therapeutics
LCTX
#8644
Rank
ยฃ91.33 M
Marketcap
ยฃ0.40
Share price
-16.02%
Change (1 day)
-48.56%
Change (1 year)

Revenue for Lineage Cell Therapeutics (LCTX)

Revenue in 2024 (TTM): ยฃ4.91 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ4.91 Million. In 2023 the company made a revenue of ยฃ7.02 Million a decrease over the revenue in the year 2022 that were of ยฃ12.15 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lineage Cell Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ4.91 M-29.97%
2023 ยฃ7.02 M-42.23%
2022 ยฃ12.15 M321.07%
2021 ยฃ2.88 M408.95%
2020 ยฃ0.56 M-49.69%
2019 ยฃ1.12 M1.04%
2018 ยฃ1.11 M-15.87%
2017 ยฃ1.32 M-26.96%
2016 ยฃ1.81 M6.25%
2015 ยฃ1.7 M36.75%
2014 ยฃ1.24 M-27.97%
2013 ยฃ1.73 M1506.23%
2012 ยฃ0.1 M-96.18%
2011 ยฃ2.82 M18.61%
2010 ยฃ2.38 M100.52%
2009 ยฃ1.18 M15.95%
2008 ยฃ1.02 M94.85%
2007 ยฃ0.52 M-11.24%
2006 ยฃ0.59 M13.27%
2005 ยฃ0.52 M46.07%
2004 ยฃ0.35 M15.27%
2003 ยฃ0.31 M28.87%
2002 ยฃ0.24 M130.37%
2001 ยฃ0.1 M138.35%
2000 ยฃ0.04 M-93.15%
1999 ยฃ0.64 M
1997 ยฃ0.36 M108.47%
1996 ยฃ0.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA